Evidence map›Paper›PMID 31483338›Full record

ReviewCurrent opinion in organ transplantation2019

Leveraging the zebrafish to model organ transplantation.

Luciana Da Silveira Cavalcante, Mehmet Toner, Korkut Uygun, Shannon N Tessier

Abstract readReview
In one paragraph

Review in Current opinion in organ transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Zebrafish as a New Tool in Heart Preservation Research.Journal of cardiovascular development and disease · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Luciana Da Silveira CavalcanteCenter for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School.
Mehmet TonerCenter for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School.
Korkut UygunCenter for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School.
Shannon N TessierCenter for Engineering in Medicine, Massachusetts General Hospital and Harvard Medical School.
Massachusetts General Hospital · USHarvard University · USShriners Hospitals for Children - Boston · US

Funding

High subzero preservation of liver for transplantationR01DK114506 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET, UYGUN, KORKUT · 2017 to 2025
$4.4M
Expanding the Liver Transplant Organ Pool through Ex Vivo Liver PerfusionR01DK107875 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MARKMANN, JAMES FRANCIS, UYGUN, KORKUT · 2016 to 2020
$2.8M
High subzero heart preservation: from zebrafish to mammalsR01HL157803 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Shannon Noella Tessier · 2021 to 2026
$2.8M
Whole heart suspended animation: leveraging the zebrafish to solve the organ shortageR00HL143149 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TESSIER, SHANNON NOELLA · 2021 to 2023
$747k
Whole heart suspended animation: leveraging the zebrafish to solve the organ shortageK99HL143149 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI TESSIER, SHANNON NOELLA · 2019 to 2020
$215k
NHLBI NIH HHS K99 HL143149NHLBI NIH HHS R00 HL143149NHLBI NIH HHS R01 HL157803NIDDK NIH HHS R01 DK107875NIDDK NIH HHS R01 DK114506
6 · The paper itself

Abstract

purpose of reviewThe availability of organs for transplant fails to meet the demand and this shortage is growing worse every year. As the cost of not getting a suitable donor organ can mean death for patients, new tools and approaches that allows us to make advances in transplantation faster and provide a different vantage point are required. To address this need, we introduce the concept of using the zebrafish (Danio rerio) as a new model system in organ transplantation. The zebrafish community offers decades of research experience in disease modeling and a rich toolbox of approaches for interrogating complex pathological states. We provide examples of how already existing zebrafish assays/tools from cancer, regenerative medicine, immunology, and others, could be leveraged to fuel new discoveries in pursuit of solving the organ shortage. RECENT

findingsImportant innovations have enabled several types of transplants to be successfully performed in zebrafish, including stem cells, tumors, parenchymal cells, and even a partial heart transplant. These innovations have been performed against a backdrop of an expansive and impressive list of tools designed to uncover the biology of complex systems that include a wide array of fluorescent transgenic fish that label specific cell types and mutant lines that are transparent, immune-deficient. Allogeneic transplants can also be accomplished using immune suppressed and syngeneic fish. Each of these innovations within the zebrafish community would provide several helpful tools that could be applied to transplant research. SUMMARY: We highlight some examples of existing tools and assays developed in the zebrafish community that could be leveraged to overcome barriers in organ transplantation, including ischemia-reperfusion, short preservation durations, regeneration of marginal grafts, and acute and chronic rejection.

Indexed as

Models, AnimalRegenerative MedicineZebrafishAnimalsHumansOrgan TransplantationTissue and Organ ProcurementTissue Donors

Identifiers

PMID31483338
PMCPMC7093753
OpenAlexW2971778036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.